Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Prevalence of sickle cell disease among Grenadian newborns.

Antoine M, Lee K, Donald T, Belfon Y, Drigo A, Polson S, Martin F, Mitchell G, Etienne-Julan M, Hardy-Dessources MD.

J Med Screen. 2018 Mar;25(1):49-50. doi: 10.1177/0969141317695356. Epub 2017 Mar 24.

PMID:
29183229
2.

CAREST--Multilingual Regional Integration for Health Promotion and Research on Sickle Cell Disease and Thalassemia.

Knight-Madden J, Romana M, Villaescusa R, Reid M, Etienne-Julan M, Boutin L, Elana G, Elenga N, Wheeler G, Lee K, Nieves R, Jones Lecointe A, Lalanne-Mistrih ML, Loko G, Keclard-Christophe L, Hardy-Dessources MD.

Am J Public Health. 2016 May;106(5):851-3. doi: 10.2105/AJPH.2016.303078. Epub 2016 Mar 21.

3.

Hydroxyurea treatment does not increase blood viscosity and improves red blood cell rheology in sickle cell anemia.

Lemonne N, Charlot K, Waltz X, Ballas SK, Lamarre Y, Lee K, Hierso R, Connes C, Etienne-Julan M, Romana M, Connes P.

Haematologica. 2015 Oct;100(10):e383-6. doi: 10.3324/haematol.2015.130435. Epub 2015 Jul 2. No abstract available.

4.

Antiplatelet antibodies detected by the MAIPA assay in newly diagnosed immune thrombocytopenia are associated with chronic outcome and higher risk of bleeding.

Grimaldi D, Canouï-Poitrine F, Croisille L, Lee K, Roudot-Thoraval F, Languille L, Khellaf M, Michel M, Godeau B, Bierling P.

Ann Hematol. 2014 Feb;93(2):309-15. doi: 10.1007/s00277-013-1855-5. Epub 2013 Aug 4.

PMID:
23912633
5.

Transplantation for liver failure in patients with sickle cell disease: challenging but feasible.

Hurtova M, Bachir D, Lee K, Calderaro J, Decaens T, Kluger MD, Zafrani ES, Cherqui D, Mallat A, Galactéros F, Duvoux C.

Liver Transpl. 2011 Apr;17(4):381-92. doi: 10.1002/lt.22257.

6.

Clinical follow-up of hydroxyurea-treated adults with sickle cell disease.

Nzouakou R, Bachir D, Lavaud A, Habibi A, Lee K, Lionnet F, Hulin A, Jouault H, Préhu C, Roudot-Thoraval F, Girot R, Galactéros F.

Acta Haematol. 2011;125(3):145-52. doi: 10.1159/000322248. Epub 2010 Dec 24.

PMID:
21196716
7.

Methylprednisolone-induced immune thrombocytopenia.

Royer B, Lee K, Gruson B, Roszkiewicz F, Al Khedr A, Colson A, Camboulives A, Bierling P, Marolleau JP.

Blood. 2010 Jul 1;115(26):5431-2. doi: 10.1182/blood-2010-01-264986. No abstract available.

8.

Identification of immunodominant alloreactive T-cell epitopes on the Jka red blood cell protein inducing either Th1 or Th2 cytokine expression.

Ansart-Pirenne H, Zeliszewski D, Lee K, Martin-Blanc S, Rouger P, Noizat-Pirenne F.

Blood. 2004 Nov 15;104(10):3409-10. No abstract available.

9.

Platelet autoantibodies and lupus-associated thrombocytopenia.

Michel M, Lee K, Piette JC, Fromont P, Schaeffer A, Bierling P, Godeau B.

Br J Haematol. 2002 Nov;119(2):354-8.

PMID:
12406068
10.

Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety.

Noizat-Pirenne F, Lee K, Pennec PY, Simon P, Kazup P, Bachir D, Rouzaud AM, Roussel M, Juszczak G, Ménanteau C, Rouger P, Kotb R, Cartron JP, Ansart-Pirenne H.

Blood. 2002 Dec 1;100(12):4223-31. Epub 2002 Aug 1.

11.

Autoimmune thrombocytopenic Purpura and Helicobacter pylori infection.

Michel M, Khellaf M, Desforges L, Lee K, Schaeffer A, Godeau B, Bierling P.

Arch Intern Med. 2002 May 13;162(9):1033-6.

PMID:
11996614

Supplemental Content

Loading ...
Support Center